Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Minerva Neurosciences, Inc (NERV) had Operating Cash Flow per Share of $-0.81 for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
-- |
|
$-8.57M |
|
-- |
|
-- |
|
$6.68M |
|
$-6.68M |
|
$-1.89M |
|
$-8.57M |
|
$-8.57M |
|
$-8.57M |
|
$-8.57M |
|
$-8.57M |
|
$-8.57M |
|
$-6.68M |
|
$-6.67M |
|
7.57M |
|
7.57M |
|
$-1.13 |
|
$-1.13 |
|
| Balance Sheet Financials | |
$35.62M |
|
$0.01M |
|
$14.89M |
|
$50.51M |
|
$2.83M |
|
-- |
|
$84.27M |
|
$87.10M |
|
$-36.59M |
|
$-51.46M |
|
$-36.59M |
|
6.99M |
|
| Cash Flow Statement Financials | |
$-6.09M |
|
-- |
|
-- |
|
$41.01M |
|
$34.92M |
|
$-6.09M |
|
$0.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.09M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
23.42% |
|
16.65% |
|
-16.96% |
|
23.42% |
|
$-5.23 |
|
$-0.81 |
|
|
Operating Cash Flow per Share |
$-0.81 |